Identification of Biological Markers of Liver X Receptor (LXR) Activation at the Cell Surface of Human Monocytes

Abstract

BackgroundLiver X receptor (LXR) α and LXR β (NR1H3 and NR1H2) are oxysterol-activated nuclear receptors involved in the control of major metabolic pathways such as cholesterol homeostasis, lipogenesis, inflammation and innate immunity. Synthetic LXR agonists are currently under development and could find applications in various fields such as cardiovascular diseases, cancer, diabetes and neurodegenerative diseases. The clinical development of LXR agonists requires the identification of biological markers for pharmacodynamic studies. In this context, monocytes represent an attractive target to monitor LXR activation. They are easily accessible cells present in peripheral blood; they express LXR α and β and respond to LXR agonist stimulation in vitro. The aim of our study was to identify cell surface markers of LXR agonists on monocytes. For this, we focused on clusters of differentiation (CD) markers because they are well characterized and accessible cell surface molecules allowing easy immuno-phenotyping.Methodology/Principal FindingsBy using microarray analysis of monocytes treated or not with an LXR agonist in vitro, we selected three CD, i.e. CD82, CD226, CD244 for further analysis by real time PCR and flow cytometry. The three CD were up-regulated by LXR agonist treatment in vitro in a time- and dose- dependent manner and this induction was LXR specific as assessed by a SiRNA or LXR antagonist strategy. By using flow cytometry, we could demonstrate that the expression of these molecules at the cell surface of monocytes was significantly increased after LXR agonist treatment.Conclusions/SignificanceWe have identified three new cell surface markers that could be useful to monitor LXR activation. Future studies will be required to confirm the biological and diagnostic significance of the markers.

Anti-Obese Effect of Glucosamine and Chitosan Oligosaccharide in High-Fat Diet-Induced Obese Rats

“…The LXR family includes both LXRα and LXRβ [ 38 , 39 , 45 ]. The latter is ubiquitously expressed, while the former is most highly expressed in the liver, adipose tissue, and macrophages [ 46 , 47 ] and is activated by glucose and sterols. In the liver, LXRα activates lipogenic and glycolytic genes following activation by its ligands partly via the activation of sterol regulatory element binding proteins (SREBPs) [ 48 , 49 ].…”

Advances in Understanding the Roles of CD244 (SLAMF4) in Immune Regulation and Associated Diseases

“…There is increasing evidence that an LXR agonist can be used to treat T1D ( 60 , 61 ). Some studies found that the presence of CD244 in monocytes was an indicator of LXR activation, and that application of an LXR agonist increased the expression of CD244 ( 62 ). This indirect connection suggests the need for future studies of the specific functions of CD244 in T1D.…”

The Inhibitory T Cell Receptors PD1 and 2B4 Are Differentially Regulated on CD4 and CD8 T Cells in a Mouse Model of Non-alcoholic Steatohepatitis

“…Besides TLR4, other receptors potentially involved in PD1 and 2B4 upregulation could be TLR2 and TLR9, as bacterial DNA as a TLR9 ligand was elevated in blood of HFD fed mice ( Miura et al, 2010 ) and free fatty acids as well as denatured host DNA could activate these two receptors in the course of NASH development ( Senn, 2006 ; Watanabe et al, 2007 ). 2B4 is upregulated on human monocytes after liver X receptor (LXR) activation ( Rébé et al, 2012 ), therefore its upregulation on hepatic T cells could also involve this nuclear receptor ( Rébé et al, 2012 ).…”